Your cart
Your cart is empty
Continue shoppingMore Information (API / 50mg x 14 tabs)
Active Ingredients
Lacosamide 50mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Pink, oval shaped, film coated tablets debossed with "LAC" on one side and "50" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 50mg
- Dosage: Tablet, film coated
- Pack Size: 14
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (API / 100mg x 14 tabs)
Active Ingredients
Lacosamide 100mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Dark yellow, oval shaped, film coated tablets debossed with "LAC" on one side and "100" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 100mg
- Dosage: Tablet, film coated
- Pack Size: 14
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (API / 100mg x 56 tabs)
Active Ingredients
Lacosamide 100mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Dark yellow, oval shaped, film coated tablets debossed with "LAC" on one side and "100" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 100mg
- Dosage: Tablet, film coated
- Pack Size: 56
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (API / 150mg x 14 tabs)
Active Ingredients
Lacosamide 150mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Peach, oval shaped, film coated tablets debossed with "LAC" on one side and "150" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 150mg
- Dosage: Tablets, film coated
- Pack Size: 14
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (API / 150mg x 56 tabs)
Active Ingredients
Lacosamide 150mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Peach, oval shaped, film coated tablets debossed with "LAC" on one side and "150" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 150mg
- Dosage: Tabs
- Pack Size: 56
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (API / 200mg x 56 tabs)
Active Ingredients
Lacosamide 200mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Blue, oval shaped, film coated tablets debossed with "LAC" on one side and "200" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 200mg
- Dosage: Tablet, film coated
- Pack Size: 56
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (Sigma / 200mg x 56 tabs)
Active Ingredients
Lacosamide 200mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Blue, oval shaped, film coated tablets debossed with "LAC" on one side and "200" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 200mg
- Dosage: Tablet, film coated
- Pack Size: 56
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (Symbion / 50mg x 14 tabs)
Active Ingredients
Lacosamide 50mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Pink, oval shaped, film coated tablets debossed with "LAC" on one side and "50" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 50mg
- Dosage: Tablet, film coated
- Pack Size: 14
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (Symbion / 100mg x 14 tabs)
Active Ingredients
Lacosamide 100mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Dark yellow, oval shaped, film coated tablets debossed with "LAC" on one side and "100" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 100mg
- Dosage: Tablet, film coated
- Pack Size: 14
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (Symbion / 100mg x 56 tabs)
Active Ingredients
Lacosamide 100mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Dark yellow, oval shaped, film coated tablets debossed with "LAC" on one side and "100" on other side.
Storage Conditions
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 100mg
- Dosage: Tablet, film coated
- Pack Size: 56
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (Symbion / 150mg x 14 tabs)
Active Ingredients
Lacosamide 150mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Peach, oval shaped, film coated tablets debossed with "LAC" on one side and "150" on other side.
Storage Conditions
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 150mg
- Dosage: Tablet, film coated
- Pack Size: 14
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (Symbion / 150mg x 56 tabs)
Active Ingredients
Lacosamide 150mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 150mg
- Dosage: Tablet, film coated
- Pack Size: 56
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (Symbion / 200mg x 56 tabs)
Active Ingredients
Lacosamide 200mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Blue, oval shaped, film coated tablets debossed with "LAC" on one side and "200" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 200mg
- Dosage: Tablet, film coated
- Pack Size: 56
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (CH2 / 50mg x 14 tabs)
Active Ingredients
Lacosamide 50mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Pink, oval shaped, film coated tablets debossed with "LAC" on one side and "50" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 50mg
- Dosage: Tablet, film coated
- Pack Size: 14
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (CH2 / 100mg x 14 tabs)
Active Ingredients
Lacosamide 100mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Dark yellow, oval shaped, film coated tablets debossed with "LAC" on one side and "100" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 100mg
- Dosage: Tablet, film coated
- Pack Size: 14
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (CH2 / 100mg x 56 tabs)
Active Ingredients
Lacosamide 100mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Dark yellow, oval shaped, film coated tablets debossed with "LAC" on one side and "100" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 100mg
- Dosage: Tablet, film coated
- Pack Size: 56
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (CH2 / 150mg x 14 tabs)
Active Ingredients
Lacosamide 150mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Peach, oval shaped, film coated tablets debossed with "LAC" on one side and "150" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 150mg
- Dosage: Tablet, film coated
- Pack Size: 14
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (CH2 / 150mg x 56 tabs)
Active Ingredients
Lacosamide 150mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Peach, oval shaped, film coated tablets debossed with "LAC" on one side and "150" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 150mg
- Dosage: Tablet, film coated
- Pack Size: 56
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
More Information (CH2 / 200mg x 56 tabs)
Active Ingredients
Lacosamide 200mg
Free-From
Indicators
Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
· add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.
· add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.
Tablet Description
Blue, oval shaped, film coated tablets debossed with "LAC" on one side and "200" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
- Generic Name: Lacosamide
- PBS Listed: ✔
- RPBS: ✘
- Strength: 200mg
- Dosage: Tablet, film coated
- Pack Size: 56
- Schedule: S4
- Shelf Life: 24 Months
- Innovator:
Warnings
Connecting Care, Simplifying Supply.
At Pharmacor, we bridge the gap between healthcare providers and seamless supply solutions, ensuring care is always within reach.
